Trade Review 3: REGN

Keeping this short as I have had long day . $Regeneron Pharmaceuticals (REGN.US)$ is a BUY and should be poised to do well in its upcoming Earnings Report.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate